Literature DB >> 7574907

CD 44 exon v6 as a predictor of lymphatic metastases in cervical carcinoma--an immunocytochemical study of 94 cases.

C Biesold1, U Köhler, L C Horn, K Bilek, R Kade, C Emmert.   

Abstract

The relation between expression of several splicing variants of the CD 44 glycoprotein by tumor cells and the increased risk of metastases was discussed recently. By means of an immunocytochemical study (imprint cytology specimens from 94 invasive cervical carcinomas) we have shown a significant correlation between expression of CD 44 v6 and invasion of lymphatic vessels, lymphangiosis carcinomatosa in the primary tumor and the total number of positive pelvic lymph nodes. Expression of CD 44 v6 was not correlated with staging, grading and histological type. CD 44 v6 could therefore be considered as a predictor of lymphatic metastases in cervical carcinoma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7574907     DOI: 10.1007/BF01314643

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  17 in total

1.  A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man.

Authors:  S T Jalkanen; R F Bargatze; L R Herron; E C Butcher
Journal:  Eur J Immunol       Date:  1986-10       Impact factor: 5.532

2.  CD44 and cancer screening.

Authors:  S B Fox; K C Gatter; D G Jackson; G R Screaton; M V Bell; J I Bell; A L Harris; D Simmons; J Fawcett
Journal:  Lancet       Date:  1993-08-28       Impact factor: 79.321

3.  Significance of CD44 gene products for cancer diagnosis and disease evaluation.

Authors:  Y Matsumura; D Tarin
Journal:  Lancet       Date:  1992-10-31       Impact factor: 79.321

4.  Expression of CD44R1 adhesion molecule in colon carcinomas and metastases.

Authors:  K K Tanabe; L M Ellis; H Saya
Journal:  Lancet       Date:  1993-03-20       Impact factor: 79.321

5.  Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.

Authors:  G R Screaton; M V Bell; D G Jackson; F B Cornelis; U Gerth; J I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

6.  Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium.

Authors:  P Dall; K H Heider; A Hekele; G von Minckwitz; M Kaufmann; H Ponta; P Herrlich
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

7.  CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation.

Authors:  H Kim; X L Yang; C Rosada; S R Hamilton; J T August
Journal:  Arch Biochem Biophys       Date:  1994-05-01       Impact factor: 4.013

8.  Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation.

Authors:  S M Denning; P T Le; K H Singer; B F Haynes
Journal:  J Immunol       Date:  1990-01-01       Impact factor: 5.422

Review 9.  CD44: the hyaluronan receptor.

Authors:  C Underhill
Journal:  J Cell Sci       Date:  1992-10       Impact factor: 5.285

10.  Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44.

Authors:  G Koopman; K H Heider; E Horst; G R Adolf; F van den Berg; H Ponta; P Herrlich; S T Pals
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.